CA Stock MarketDetailed Quotes

GTTX GeneTether Therapeutics Inc

Watchlist
  • 0.045
  • +0.005+12.50%
15min DelayMarket Closed Dec 13 10:13 ET
1.74MMarket Cap-3.21P/E (TTM)

GeneTether Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-29.04%966.11K
-28.07%1.03M
-25.37%1.25M
-24.06%1.36M
-24.06%1.36M
-32.23%1.36M
-39.55%1.43M
-45.93%1.68M
898.49%1.8M
898.49%1.8M
-Cash and cash equivalents
-29.04%966.11K
-28.07%1.03M
-25.37%1.25M
-24.06%1.36M
-24.06%1.36M
-32.23%1.36M
-39.55%1.43M
-45.93%1.68M
898.49%1.8M
898.49%1.8M
Receivables
-45.79%49.77K
-48.00%73.27K
-86.41%1.5K
-68.17%47.27K
-68.17%47.27K
--91.82K
--140.9K
--11.01K
--148.49K
--148.49K
-Other receivables
-45.79%49.77K
-48.00%73.27K
-86.41%1.5K
-68.17%47.27K
-68.17%47.27K
--91.82K
--140.9K
--11.01K
--148.49K
--148.49K
Total current assets
-30.10%1.02M
-29.86%1.1M
-25.77%1.25M
-27.43%1.41M
-27.43%1.41M
-35.34%1.45M
-41.70%1.57M
-48.37%1.69M
424.80%1.94M
424.80%1.94M
Non current assets
Total non current assets
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total assets
-30.10%1.02M
-29.86%1.1M
-25.77%1.25M
-27.43%1.41M
-27.43%1.41M
-35.34%1.45M
-41.70%1.57M
-48.37%1.69M
424.80%1.94M
424.80%1.94M
Liabilities
Current liabilities
Payables
-2.97%29.43K
-39.90%23.23K
-44.07%54.86K
-55.85%38.59K
-55.85%38.59K
-73.33%30.33K
-70.22%38.65K
-65.69%98.1K
-59.00%87.42K
-59.00%87.42K
-accounts payable
-2.97%29.43K
-39.90%23.23K
-44.07%54.86K
-55.85%38.59K
-55.85%38.59K
-73.33%30.33K
-70.22%38.65K
-65.69%98.1K
-59.00%87.42K
-59.00%87.42K
Current liabilities
-2.97%29.43K
-39.90%23.23K
-44.07%54.86K
-55.85%38.59K
-55.85%38.59K
-73.33%30.33K
-70.22%38.65K
-65.69%98.1K
-59.00%87.42K
-59.00%87.42K
Non current liabilities
Total non current liabilities
0.00%-1
---1
--0
--0
--0
-200.00%-1
--0
--0
--0
--0
Total liabilities
-2.97%29.42K
-39.90%23.23K
-44.07%54.86K
-55.85%38.59K
-55.85%38.59K
-73.33%30.33K
-70.22%38.65K
-65.69%98.1K
-59.00%87.42K
-59.00%87.42K
Shareholders'equity
Share capital
0.03%4.2M
0.12%4.2M
0.28%4.2M
0.51%4.2M
0.51%4.2M
0.81%4.2M
1.14%4.19M
1.27%4.19M
234.56%4.18M
234.56%4.18M
-common stock
0.03%4.2M
0.12%4.2M
0.28%4.2M
0.51%4.2M
0.51%4.2M
0.81%4.2M
1.14%4.19M
1.27%4.19M
234.56%4.18M
234.56%4.18M
Additional paid-in capital
19.33%1.66M
13.10%1.64M
14.90%1.64M
10.60%1.63M
10.60%1.63M
-1.83%1.39M
8.88%1.45M
17.52%1.42M
87.32%1.48M
87.32%1.48M
Retained earnings
-17.57%-4.66M
-15.13%-4.53M
-16.54%-4.43M
-19.15%-4.28M
-19.15%-4.28M
-23.30%-3.97M
-39.91%-3.94M
-61.05%-3.8M
-91.29%-3.59M
-91.29%-3.59M
Gains losses not affecting retained earnings
-4.82%-205.34K
-32.46%-219.19K
5.63%-206.91K
12.96%-174.87K
12.96%-174.87K
13.66%-195.9K
-86.91%-165.48K
-66,945.12%-219.25K
---200.92K
---200.92K
Total stockholders'equity
-30.68%986.46K
-29.60%1.08M
-24.64%1.2M
-26.09%1.37M
-26.09%1.37M
-33.31%1.42M
-40.26%1.54M
-46.71%1.59M
1,080.92%1.86M
1,080.92%1.86M
Total equity
-30.68%986.46K
-29.60%1.08M
-24.64%1.2M
-26.09%1.37M
-26.09%1.37M
-33.31%1.42M
-40.26%1.54M
-46.71%1.59M
1,080.92%1.86M
1,080.92%1.86M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -29.04%966.11K-28.07%1.03M-25.37%1.25M-24.06%1.36M-24.06%1.36M-32.23%1.36M-39.55%1.43M-45.93%1.68M898.49%1.8M898.49%1.8M
-Cash and cash equivalents -29.04%966.11K-28.07%1.03M-25.37%1.25M-24.06%1.36M-24.06%1.36M-32.23%1.36M-39.55%1.43M-45.93%1.68M898.49%1.8M898.49%1.8M
Receivables -45.79%49.77K-48.00%73.27K-86.41%1.5K-68.17%47.27K-68.17%47.27K--91.82K--140.9K--11.01K--148.49K--148.49K
-Other receivables -45.79%49.77K-48.00%73.27K-86.41%1.5K-68.17%47.27K-68.17%47.27K--91.82K--140.9K--11.01K--148.49K--148.49K
Total current assets -30.10%1.02M-29.86%1.1M-25.77%1.25M-27.43%1.41M-27.43%1.41M-35.34%1.45M-41.70%1.57M-48.37%1.69M424.80%1.94M424.80%1.94M
Non current assets
Total non current assets --0--0--0--0--0--0--0--0--0--0
Total assets -30.10%1.02M-29.86%1.1M-25.77%1.25M-27.43%1.41M-27.43%1.41M-35.34%1.45M-41.70%1.57M-48.37%1.69M424.80%1.94M424.80%1.94M
Liabilities
Current liabilities
Payables -2.97%29.43K-39.90%23.23K-44.07%54.86K-55.85%38.59K-55.85%38.59K-73.33%30.33K-70.22%38.65K-65.69%98.1K-59.00%87.42K-59.00%87.42K
-accounts payable -2.97%29.43K-39.90%23.23K-44.07%54.86K-55.85%38.59K-55.85%38.59K-73.33%30.33K-70.22%38.65K-65.69%98.1K-59.00%87.42K-59.00%87.42K
Current liabilities -2.97%29.43K-39.90%23.23K-44.07%54.86K-55.85%38.59K-55.85%38.59K-73.33%30.33K-70.22%38.65K-65.69%98.1K-59.00%87.42K-59.00%87.42K
Non current liabilities
Total non current liabilities 0.00%-1---1--0--0--0-200.00%-1--0--0--0--0
Total liabilities -2.97%29.42K-39.90%23.23K-44.07%54.86K-55.85%38.59K-55.85%38.59K-73.33%30.33K-70.22%38.65K-65.69%98.1K-59.00%87.42K-59.00%87.42K
Shareholders'equity
Share capital 0.03%4.2M0.12%4.2M0.28%4.2M0.51%4.2M0.51%4.2M0.81%4.2M1.14%4.19M1.27%4.19M234.56%4.18M234.56%4.18M
-common stock 0.03%4.2M0.12%4.2M0.28%4.2M0.51%4.2M0.51%4.2M0.81%4.2M1.14%4.19M1.27%4.19M234.56%4.18M234.56%4.18M
Additional paid-in capital 19.33%1.66M13.10%1.64M14.90%1.64M10.60%1.63M10.60%1.63M-1.83%1.39M8.88%1.45M17.52%1.42M87.32%1.48M87.32%1.48M
Retained earnings -17.57%-4.66M-15.13%-4.53M-16.54%-4.43M-19.15%-4.28M-19.15%-4.28M-23.30%-3.97M-39.91%-3.94M-61.05%-3.8M-91.29%-3.59M-91.29%-3.59M
Gains losses not affecting retained earnings -4.82%-205.34K-32.46%-219.19K5.63%-206.91K12.96%-174.87K12.96%-174.87K13.66%-195.9K-86.91%-165.48K-66,945.12%-219.25K---200.92K---200.92K
Total stockholders'equity -30.68%986.46K-29.60%1.08M-24.64%1.2M-26.09%1.37M-26.09%1.37M-33.31%1.42M-40.26%1.54M-46.71%1.59M1,080.92%1.86M1,080.92%1.86M
Total equity -30.68%986.46K-29.60%1.08M-24.64%1.2M-26.09%1.37M-26.09%1.37M-33.31%1.42M-40.26%1.54M-46.71%1.59M1,080.92%1.86M1,080.92%1.86M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.